Heparin Therapy Leads to Platelet Activation and Prolongation of Platelet Function Analyser-100 Closure Time

Williams MS , Ng’alla LS. Heparin therapy leads to platelet activation and prolongation of PFA-100 closure time. J Cardiovasc Pharmacol Ther. 2005;10:273-280.

Barradas MA , Mikhailidis DP , Epemolu O , Jeremy JY , Fonseca V , Dandona P. Comparison of the platelet pro-aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222). Br J Haematol. 1987;67:451-457.

Greenbaum RA , Barradas MA , Mikhailidis DP , Jeremy JY , Evans TR , Dandona P. Effect of heparin and contrast medium on platelet function during routine cardiac catheterisation. Cardiovasc Res. 1987;21:878-885.

Jagroop IA , Barradas MA , Mikhailidis DP. A low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin-induced platelet shape change and does not enhance spontaneous platelet aggregation. Br J Clin Pharmacol. 1996;41: 163-165.

Mikhailidis DP , Barradas MA , Mikhailidis AM , Magnani H , Dandona P. Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function. Br J Clin Pharmacol. 1984;17:43-48.

Mikhailidis DP , Barradas MA , Jeremy JY , Gracey L , Wakeling A , Dandona P. Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease. Eur J Clin Invest. 1985;15: 313-319.

Mikhailidis DP , Barradas MA , Maris A , Jeremy JY , Dandona P. Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease. J Clin Pathol. 1985;38: 1166-1171.

Mikhailidis DP , Barradas MA , Dandona P. Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathway. Thromb Res. 1986;42: 719-720.

Mikhailidis DP , Fonseca VA , Barradas MA , et al. Platelet activation following intravenous injection of a conventional heparin: absence of effect with a low molecular weight heparinoid (Org 10172). Br J Clin Pharmacol. 1987;24:415-424.

Mikhailidis DP , Barradas MA , Mier A , et al. Platelet function in patients admitted with a diagnosis of myocardial infarction. Angiology. 1987;38:36-45.

Grace AA , Barradas MA , Mikhailidis DP , et al. Cyclosporine A enhances platelet aggregation. Kidney Int. 1987;32:889-895.

Barradas MA , Mikhailidis DP , Dandona P. The effect of non-esterified fatty acids on vascular ADP-degrading enzyme activity. Diabetes Res Clin Pract. 1987;3:9-19.

Mikhailidis DP , Barradas MA , Jeremy JY , Dandona P. Cigarette smoking inhibits prostacyclin formation. Lancet. 1983;2:627-628.

Mikhailidis DP , Mikhailidis AM , Woollard ML , Dandona P. Protection of prostacyclin-like activity in human plasma-a non-enzymatic mechanism? Clin Sci (Lond). 1982;62:177-181.

Mikhailidis DP , Mikhailidis AM , Dandona P. Effect of human plasma proteins on stabilisation of platelet anti-aggregatory activity of prostacyclin. Ann Clin Biochem. 1982;19:241-244.

Klinkhardt U , Graff J , Westrup D , et al. Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects. Br J Clin Pharmacol. 2001;52: 297-305.

Mohammed SF , Anderson WH , Smith JB , Chuang HY , Mason RG. Effects of heparin on platelet aggregation and release on thromboxane A2 production. Am J Pathol. 1981;104:132-141.

Westwick J , Scully MF , Poll C , Kakkar VV. Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro. Thromb Res. 1986;42:435-447.